Brazil’s medicines regulator, ANVISA, has been elected to the International Council for Harmonisation management committee, a move that the agency claims will give it a louder voice in setting international regulatory guidelines. Brazil’s pharma industry has welcomed the news.
The ICH Assembly elected ANVISA to the ICH management board at a 19 November meeting in Singapore. ANVISA’s tenure on...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?